Press Releases
![2022-3-30-Olympic-Ophthalmics-Announces-FDA-Clearance](https://olympicophthalmics.com/wp-content/uploads/2022/06/2022-3-30-Olympic-Ophthalmics-Announces-FDA-Clearance.png)
March 30, 2022
Olympic Ophthalmics Announces FDA Clearance and Availability of Its Next-Generation iTEAR®100 Neurostimulation Device, Expanded Patent Portfolio, and Further Clinical Studies
![2-Arctic-Vision-Announces-Exclusive-Licensing-Agreement with-Olympic-Ophthalmics-for-iTEAR®100-june6-2021](https://olympicophthalmics.com/wp-content/uploads/2022/01/2-Arctic-Vision-Announces-Exclusive-Licensing-Agreement-with-Olympic-Ophthalmics-for-iTEAR®100-june6-2021.png)
Jun 06, 2021
Arctic Vision Announces Exclusive Licensing Agreement with Olympic Ophthalmics for iTEAR®100 for the Treatment of Dry Eye Disease in Greater China, South Korea and ASEAN Countries.
![3-Olympic-Ophthalmics-Announces-Issuance-of-Two-Seminal-Patents-for-its-Neuromodulation-Technology-apr22-2021](https://olympicophthalmics.com/wp-content/uploads/2022/01/3-Olympic-Ophthalmics-Announces-Issuance-of-Two-Seminal-Patents-for-its-Neuromodulation-Technology-apr22-2021.png)
April 22, 2021
Olympic Ophthalmics Announces Issuance of Two Seminal Patents for its Neuromodulation Technology.
![2020-9-15-Dry-Eye-The-Nose-Knows](https://olympicophthalmics.com/wp-content/uploads/2022/06/2020-9-15-Dry-Eye-The-Nose-Knows.png)
September 15, 2020
Dry Eye: The Nose Knows
Learn how neurostimulation is becoming a viable treatment option for patients who have exhausted their options.
![2019-6-15-Dry-Eye-Therapy-Getting-Nosy](https://olympicophthalmics.com/wp-content/uploads/2022/06/2019-6-15-Dry-Eye-Therapy-Getting-Nosy.png)
June 15, 2019
Dry Eye Therapy: Getting Nosy
Understand the science behind nasal stimulation.
![5-Rendia-resources-insights-new-neurostimulation-device-june3-2020](https://olympicophthalmics.com/wp-content/uploads/2022/01/5-Rendia-resources-insights-new-neurostimulation-device-june3-2020.png)